Table 1 Patient and treatment characteristics
Characteristics | Patients, n = 61 |
|---|---|
Median age (range) | 65 (40–84) |
Sex | |
Male | 29 (48%) |
Female | 32 (53%) |
Race | |
White | 39 (64%) |
Black | 21 (34%) |
Other | 1 (2%) |
Histology | |
Adenocarcinoma | 30 (49%) |
Squamous | 18 (30%) |
NSCLC NOS* | 13 (21%) |
T Stage | |
T1 | 9 (15%) |
T2 | 20 (33%) |
T3 | 11 (18%) |
T4 | 19 (31%) |
Tx | 2 (3%) |
N Stage | |
N0 | 1 (2%) |
N2 | 32 (52%) |
N3 | 28 (46%) |
AJCC Stage (V.7) | |
IIIA | 22 (36%) |
IIIB | 39 (64%) |
Radiation Technique | |
3-D Conformal | 45 (74%) |
IMRT | 9 (15%) |
3-D Conformal & IMRT | 7 (11%) |
Radiation Dose, median (range) | 66 Gy (39.6-74 Gy) |
Treatment Planning Margins, median (range) | |
GTV to CTV expansion | 0.5 cm (0–1 cm) |
CTV to PTV expansion | 1 cm (0.3-2.5 cm) |
Use of daily On-board Imaging (OBI) | 24 (39%) |
Concurrent Chemotherapy | 55 (90%) |